## 

||||Contents||
|---|---|---|---|---|
|||||Page|
|Trustees'|Report|||1-3|
|Independent<br>Examiners||Report|||
|Statement|of Financial|Activities|||
|Statement|of Financial|Position (Balance Sheet)|||
|Statement|ofCash Flows||||
|Notes to the Financial Statements||||8-9|





|Registered<br>charity name||The Erosive Toothwear|Foundation|
|---|---|---|---|
|Charity Commission<br>registration||1173340||
|Registrar ofCompanies|registration|CE011019||
|Principal<br>and registered|office|Guys Hospital||



|The charity|The charity|is known as ETWF and will be referred to by that name|in this report.|||
|---|---|---|---|---|---|
|The trustees||||Professor|David Bartlett|
|||||Professor|Nigel Pitts|
|External|Examiners|||Elizabeth|Paterson|
|||||Han &Co Accountants||
|||||61 Scott Street||
|||||Dundee||
|||||DD2 2BA||
|Bankers||||Bl|Bank|



## 



## 

## 

## 

## 

## 

## 

## 

## 



## 

## 

## 

## 



## 

## 

## 

## 



|||||Note|2021||2021||2021|2020|
|---|---|---|---|---|---|---|---|---|---|---|
||||||Unrestricted|Funds|Restricted|Funds|Total|Total|
||||||L'||||1'|1|
|Income|||||||||||
|Donations||||||30,000|||30,000|47,100|
|Total income||||||30,000|||30,000|47,100|
|Expenditure|||||||||||
|Expenditure<br>on|charitable||activities|||36,602|||36,602|47,119|
|Total expenditure||||||36,602|||36,602|47,119|
|Reconciliation|offunds||||||||||
|Net movement|in|funds||||(6,602)|||(6,602)|(19)|
|Balances brought||forward||||50,645|||50,645|50,664|
|Balances carried||forward||||44,043|||44,043|50,645|





||Note||2021I|2020<br>L'|
|---|---|---|---|---|
|Fixed assets|||||
|Tangible assets|||458|609|
|Current assets|||||
|Debtors and prepayments|||18,653|12,215|
|Bank and cash|||25,652|39,021|
||||44,305|51,236|
|Current<br>liabilities|||||
|Creditors|||720|1,200|
|Net current assets/(liabilities)|||43,585|50,036|
|Net assets|||44,043|50,645|
|Represented<br>by:|||||
|Unrestricted<br>funds|||44,043|50,645|
|Restricted<br>funds|||||
|Total funds|||44,043|50,645|
|Signed on behalf ofthe Board|||||
|Signature||Date|||





## 

||||||2021|2020|
|---|---|---|---|---|---|---|
||||||L'|L'|
|Cash flows|from operating||activities||||
|Net income|||||(6,602)|(19)|
|Adjustments|for:||||||
|Depreciation|||||152|204|
|Changes<br>in:|||||||
|Debtors|||||(6,439)|(6,700)|
|Creditors|||||(480)||
|Net cash from operating||activites|||(13,369)|(6,515)|
|Net decrease|in cash and cash equivalents||||(13,369)|(6,515)|
|Cash and cash equivalents|||at beginning|ofyear|39,021|45,536|
|Cash and cash equivalents|||at end of|year|25,652|39,021|





## 

## 

## 

## 

||2021||2021||2021|2020|
|---|---|---|---|---|---|---|
||Unrestricted|Funds|Restricted|Funds|Total|Total|
||L'||L'||L'|F|
|Donations|||||||
|Grants|||||||
|GSK||15,000||||30,000|
|KCL||||||2,100|
|Proctor and Gamble||15,000|||||
|Unilever||||||15,000|
|||30,000|||30,000|47,100|



## 

|||2021||2021||2021||
|---|---|---|---|---|---|---|---|
|||Unrestricted|Funds|Restricted|Funds|Total||
|||||||L'||
|Charitable|activities||35,630|||35,630||
|Governance|costs||972||||972|
||||36,602|||36,602||




## 




## 

## 

|||||||2021||2020|
|---|---|---|---|---|---|---|---|---|
|||||||||E|
||Trade creditors|||and accruals||720||1,200|
|6|Analysis|offunds|||||||
||||||31st|Income|Expenditure|31st|
||||||December|||December|
||||||2020|||2021|
||Restricted||Funds||||||
||Unrestricted||Funds||50,645|30,000|36,602|44,043|
||Total Funds||||50,645|30,000|36,602|44,043|



##